Prospective multicenter prolase II clinical trial of neodymium:yttrium- aluminum-garnet laser prostatectomy

Urology

Volumn 50, Issue 1, 1997, Pages 63-65

  Kabalin, John N ^a   Gill, Harcharan S ^b   Leach, Gary E ^b   Bowers, George W ^b   Nill, Thomas ^b   Konowalchuk, Thomas W ^b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER NECK STENOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEODYMIUM LASER; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATECTOMY; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; FOLLOW-UP STUDIES; HUMANS; LASER SURGERY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC HYPERPLASIA; URODYNAMICS;

EID: 0030857072     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00117-9     Document Type: Article

References (13)

1. Kabalin JN, Gill HS, Bite G, and Wolfe V: Comparative study of laser versus electrocautery prostatic resection: 18-month followup with complex urodynamic assessment. J Urol 153: 94-98, 1995.
2. Costello AJ, Lusaya DG, and Crowe HR: Transurethral laser ablation of the prostate - long-term results. World J Urol 13: 119-122, 1995.
3. Kabalin JN, Gill HS, and Bite G: Laser prostatectomy performed with a right-angle firing neodymium:YAG laser fiber at 60 watts power setting. J Urol 153: 1502-1505, 1995.
4. Cowles RS III, Kabalin JN, Childs S, Lepor H, Dixon C, Stein B, and Zabbo A: A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia. Urology 46: 155-160, 1995.
5. Anson K, Nawrocki J, Buckley J, Fowler C, Kirby R, Lawrence W, Paterson P, and Watson G: A multicenter, randomized, prospective study of endoscopic laser ablation versus transurethral resection of the prostate. Urology 46: 305-310, 1995.
6. Kabalin JN, Bite G, and Doll S: Neodymium:YAG laser coagulation prostatectomy: 3 years of experience with 227 patients. J Urol 155: 181-185, 1996.
7. Leach GE, Sirls L, Ganabathi K, Roskamp D, and Dmochowski R: Outpatient visual laser-assisted prostatectomy under local anesthesia. Urology 43: 149-153, 1994.
8. Gill HS, Kabalin JN, and Mikus PW: Characterization of tissue effects produced by the ProLase II lateral-firing neodymium:YAG laser fiber in the canine prostate. Lasers Surg Med 15: 185-190, 1994.
9. Kabalin JN, Sellers R, and Bite G: Neodymium:yttrium-aluminum-garnet laser dosimetry for the ProLase II side-firing delivery system in the human prostate. Urology 45: 248-252, 1995.
10. McConnell JD, Barry MJ, Bruskewitz RC, Bueschen AJ, Denton SE, Holtgrewe HL, Lange JL, McClennan BL, Mebust WK, Reilly NJ, et al: Benign Prostatic Hyperplasia: Diagnosis and Treatment. Clinical Practice Guideline, Number 8. AHCPR Publication No. 94-0582. Rockville, MD, Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services, 1994.
11. Kabalin JN, and Gill HS: Urolase laser prostatectomy in patients on warfarin anticoagulation: a safe treatment alternative for bladder outlet obstruction. Urology 42: 738-740, 1993.
12. Kingston TE, Nonnenmacher AK, Crowe H, Costello AJ, and Street A: Further evaluation of transurethral laser ablation of the prostate in patients treated with anticoagulant therapy. Aust NZ J Surg 65: 40-43, 1995.
13. Kabalin JN, and Butler ED: Costs of minimally invasive laser surgery compared with transurethral electrocautery resection of the prostate. West J Med 162: 426-429, 1995.